Desk›Healthcare› Indoco Remedies Ltd
Indoco Remedies Ltd
BSE 532612 · NSE INDOCO · ISIN INE873D01024 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹242.30
+1.44%
BSE close, 28 August 2026
₹2,236.52 cr
9.2 cr shares · Micro cap
₹885.70 cr
as published
21.4× · 1.96×
EPS ₹11.35 · BV ₹123.62
1,686.07 / -5.66
₹ cr, as filed
25
5 selected · 20%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -27.1% |
|---|---|
| Against 52-week low | +48.0% |
| Day change | +1.44% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹11.35 |
|---|---|
| Price / earnings | 21.35× |
| Price / book | 1.96× |
| Book value — derived, price ÷ P/B | ₹123.62 |
| Return on equity | 9.17% |
| Operating margin | 35.22% |
| Net margin | 20.13% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 9.18%
- ROE as published
- 9.17%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 408.97 | 82.32 | 8.92 | 35.22% | 20.13% |
| Mar-26 · Q | 449.13 | 27.35 | 2.96 | 17.16% | 6.09% |
| FY25-26 | 1,686.07 | -5.66 | -0.61 | 10.91% | -0.34% |
Quarter on quarter
- Revenue, quarter on quarter
- -8.9%
- Net profit, quarter on quarter
- +201.0%
- Operating margin, quarter on quarter
- +1,806 bps
Disclosure profile 25 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Concall Transcript | 1 |
| Contract / MoU | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| AGM / EGM | 4 |
| General | 3 |
| SAST | 3 |
| Newspaper Publication | 2 |
| Subsidiary Incorporation | 2 |
| Analyst / Investor Meet | 1 |
| Annual Report | 1 |
| BRSR | 1 |
| Compliance Certificate | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 20 |
| Total | 25 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
25 filings · 5 selected · busiest 2026-08-21
Filing rhythm · the twelve most recent
2026-09-012026-10-07
SelectedProcedural
Filings
25 in the window · 6 earlier on record
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attached the certificate issued by MUFG Intime India Private Ltd, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI(D & P) Regulations,2018 ....
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
29 September 2026 ·
Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory Furnishing Of PAN, KYC And Bank Details As Per SEBI Master Circular No. HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 Dated February 6, 2026
Pursuant to Regulation 30 and Part A of Schedule III of SEBI (LODR) Regulations,2015, please find enclosed a copy of the letter dispatched to shareholders holding shares in physical mode, ....
Company Update / General View filing →
-
28 September 2026 ·
Acquisition
Pursuant to Regulation 30 of the SEBI (LODR) Regulations,2015, please note that the Company received intimation today that the Wholly Owned Subsidiary of the Company in the name and style ....
Company Update / Acquisition View filing →
-
28 September 2026 ·
Closure of Trading Window
Intimation regarding Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015-ESG rating
Company Update / General View filing →
-
18 September 2026 ·
Acquisition
Pursuant to Regulation 30 of SEBI LODR, the Committee of Executive Directors in its meeting held today i.e. 18th September, 2026 has considered and approved the incorporation of the wholly ....
Company Update / Acquisition View filing →
-
18 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please find enclosed herewith the details of Voting Results and Scrutinizers Report for the 79th AGM of the Company held on 17th September, 2026
AGM/EGM / AGM View filing →
-
17 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
We are submitting herewith the details regarding the Proceedings of the 79th AGM of the Company held on Thursday, 17th September, 2026 at 10.30 am through video conferencing(VC)/other audio ....
AGM/EGM / AGM View filing →
-
10 September 2026 ·
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations,2015
UK MHRA inspection at Company's manufacturing facility at Plant I (solid oral dosage form) located at Goa.
Company Update / General View filing →
-
10 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
3 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi Panandikar & Others
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
1 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
27 August 2026 ·
Memorandum of Understanding /Agreements
Intimation of execution of Deed of Conveyance for Sale of Company's plot of land.
Company Update / Memorandum of Understanding /Agreements View filing →
-
21 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Reporting (BRSR)
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
21 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for the financial year 2025-2026
Others / Reg. 34 (1) Annual Report View filing →
-
21 August 2026 ·
Notice Of 79Th Annual General Meeting And Annual Report For The Financial Year 2025-2026
Notice of 79th Annual General Meeting and Annual Report for the Financial year 2025-2026
AGM/EGM / AGM View filing →
-
21 August 2026 ·
Notice Of 79Th Annual General Meeting And Annual Report For The Financial Year 2025-2026
Notice of 79th Annual General Meeting and Annual Report for the financial year 2025-2026
AGM/EGM / AGM View filing →
-
21 August 2026 ·
Intimation Of Cut-Off Date For E-Voting, Book Closure And Record Date For Dividend
Intimation of Cut-Off Date for E voting, Book Closure and Record date for Dividend
Corp. Action / Record Date View filing →
-
20 August 2026 ·
Newspaper Publication
Publication of Newspaper Advertisement- 79th Annual General Meeting to be held on 17th September, 2026 through VC/OAVM
Company Update / Newspaper Publication View filing →
-
4 August 2026 ·
Earnings Call Transcript
Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30-06-2026
Company Update / Earnings Call Transcript View filing →
-
29 July 2026 ·
Newspaper Publication
Publication of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2026
Company Update / Newspaper Publication View filing →
-
28 July 2026 ·
Analyst / Investor Meet - Outcome
Audio recording of Earnings Conference Call on Unaudited Standalone & Consolidated Financial Results for the quarter ended 30-06-2026
Company Update / Analyst / Investor Meet View filing →
-
28 July 2026 ·
Change in Management
The Board of Directors in its Meeting held today i.e. 28th July, 2026 has considered and approved 1. Re-appointment of Ms. Aditi Panandikar as the Managing Director of the Company for ....
Company Update / Change in Management View filing →
-
28 July 2026 ·
Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2026 Along With Limited Review Report
Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June, 2026 along with Limited Review Report
Result / Financial Results View filing →
-
28 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th July, 2026
Pursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors ....
Board Meeting / Outcome of Board Meeting View filing →
RSS feed for Indoco Remedies Ltd · the 50 most recent filings